Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 122

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 122
---
shareholders will represent a smaller percentage of our total outstanding Ordinary Shares after any such issuance.

The following table sets forth
the amount of gross proceeds we may receive from the Selling Shareholder from our sale of Purchase Shares that we may issue and sell to
the Selling Shareholder from time to time under the Purchase Agreement assuming that all such Purchase Shares are sold at varying purchase
prices designated below:

| Assumed Purchase Price 
 Per Share (1)          |         |     | Total Number of Purchase Shares to be Issued if 
 Full Purchase                                   |            |     | Percentage of Outstanding                  
 Ordinary Shares After Giving Effect to the 
 Issuance of Purchase Shares to Selling     
 Shareholder (2)                            |       |     | Proceeds from the Sale of the Purchase Shares to the Selling 
 Shareholder (3)                                              |            |
|:-----------------------|--------:|:----|:------------------------------------------------|-----------:|:----|:-------------------------------------------|:------|:----|:-------------------------------------------------------------|-----------:|
| $                      |    1.00 |     |                                                 | 35,000,000 |     |                                            | 98.1% |     | $                                                            | 35,000,000 |
| $                      | 4.13(4) |     |                                                 |  8,474,576 |     |                                            | 92.7% |     | $                                                            | 35,000,000 |
| $                      |    5.00 |     |                                                 |  7,000,000 |     |                                            | 91.3% |     | $                                                            | 35,000,000 |
| $                      |   10.00 |     |                                                 |  3,500,000 |     |                                            | 84.0% |     | $                                                            | 35,000,000 |
| $                      |   15.00 |     |                                                 |  2,333,333 |     |                                            | 77.7% |     | $                                                            | 34,999,995 |

__________________

| (1) | The purchase price assumes a discount to the market price of our shares, in accordance with the terms 
 of the Purchase Agreement.                                                                            |

| 60 |

| (2) | The denominator is based on 6,685,918,922 Ordinary Shares outstanding as of January 15, 2025, adjusted                                          
 to include the issuance of the number of Purchase Shares set forth in